TDI-01

DB19450InvestigationalSmall molecule

TDI-01 is a small molecule is being developed by Beijing Tide Pharmaceutical.

Mechanism: Pharmacologically active on Rho-associated protein kinase 2
Curator reviewed
Code names: TDI-01

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with TDI-01, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.